Top sale Tranexamic...

Top sale Tranexamic acid 99%

Top sale Tranexamic acid 99%

Min.Order / FOB Price:Get Latest Price

25 Kilogram

FOB Price: USD 1.0000

  • Min.Order :25 Kilogram
  • Purity: 99%min
  • Payment Terms : T/T,

Keywords

Tranexamic acid 1197-18-8 aminomethylbenzoic acid

Quick Details

  • Appearance:White powder
  • Application:Tranexamic acid for aminomethylbenzoic acid derivatives, is a kind of fibrinolytic hemostatic drug resistance, hemostatic mechanism with the same amino caproic acid, aminomethylbenzoic acid, but the e
  • PackAge:25kg/drum
  • ProductionCapacity:10000|Kilogram|Month
  • Storage:Store in dry,ventilated place under normal temperature
  • Transportation:by EMS,FEDEX

Superiority:

1,In No Less five years exporting experience.

2.Lower Price with higher quality

3,Free sample

4,We are sincerely responsible for the "product quality" and "After Service"

Onchem specialized in APIs, chemical intermediates, herbal extract , pharmaceutical raw materials and health food supplement

Details:

Company Introduction:

Onchem (China) Co.,Ltd  is a comprehensive manufacturer and an international distribution of chemicals throughout the world. Specialized in APIs, chemical intermediates, herbal extract and pharmaceutical raw materials. 

 

Product Detailed

Tranexamic acid

CAS No.: 1197-18-8

MF: C8H15NO2

MW.: 157.21

Purity:Min 99%

Appearance: White powder

Packing: 25 KG/Drum

 

 

Storage:2 year

Sample: we provide free sample.

Delivery:3days by EMS,FEDEX,

Usage

 

Tranexamic acid for aminomethylbenzoic acid derivatives, is a kind of fibrinolytic hemostatic drug resistance, hemostatic mechanism with the same amino caproic acid, aminomethylbenzoic acid, but the effect is stronger, the intensity of 7 ~ 10 times that of amino caproic acid, aminomethylbenzoic acid 2 times, and similar toxicity. Tranexamic acid structure similar to the lysine, can be competitive inhibitory fibrinolytic enzyme on the fibrous protein adsorption, prevent its activation, protect the fibrin degradation by fibrinolytic enzyme and dissolved, ultimately achieve hemostatic effect. Limitations are suitable for the treatment of acute or chronic, or systemic primary fibrinolysis hyperfunction caused by all kinds of bleeding, such as the obstetric hemorrhage, renal hemorrhage, prostatic hypertrophy, hemorrhage, hemophilia, tuberculosis, coughing up blood, stomach bleeding, liver, lung, spleen and other visceral bleeding after the operation, etc; When the operation can also be used for abnormal bleeding and so on.

 

 

 

 

Factory Picture:

 

 

Welcome to our Onchem (China) Co.,Ltd, and welcome to inquiry me about all our products, we will provide the competitive price for u. We are sincerely responsible for the "product quality" and "After Service"

 

 

Related Searches

Confirm to collect the product to my collection?

OKCancel

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View